ArticlePharmaceutical science advances2025

Enhancing ferroptosis and inhibiting ABCB1 make the novel aldose reductase inhibitor 5F-E a promising sensitizer in liver cancer.

Ziyou Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.